BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22246152)

  • 1. Extraskeletal osteosarcoma of the breast in an adolescent girl.
    Zils K; Ebner F; Ott M; Müller J; Baumhoer D; Greulich M; Rehnitz D; Rempen A; Schaetzle S; Wilhelm M; Bielack S
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):e261-3. PubMed ID: 22246152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy for pediatric osteosarcoma patients.
    Uchida A; Myoui A; Araki N; Yoshikawa H; Shinto Y; Ueda T
    Cancer; 1997 Jan; 79(2):411-5. PubMed ID: 9010116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results.
    Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A
    Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
    J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic osteosarcoma.
    Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
    Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients.
    Le Deley MC; Guinebretière JM; Gentet JC; Pacquement H; Pichon F; Marec-Bérard P; Entz-Werlé N; Schmitt C; Brugières L; Vanel D; Dupoüy N; Tabone MD; Kalifa C;
    Eur J Cancer; 2007 Mar; 43(4):752-61. PubMed ID: 17267204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.
    Miser JS; Pritchard DJ; Rock MG; Shives TC; Gilchrist GS; Smithson WA; Arndt CA; Edmonson JH; Schaid DJ
    Cancer Treat Res; 1993; 62():333-8. PubMed ID: 8096748
    [No Abstract]   [Full Text] [Related]  

  • 10. Epithelioid osteosarcoma of the jaw.
    Cozza R; Devito R; De Ioris MA; Zama M; Boldrini R; Fidani P; Donfrancesco A
    Pediatr Blood Cancer; 2009 Jul; 52(7):877-9. PubMed ID: 19202567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell osteosarcoma successfully treated by high-dose ifosfamide and methotrexate, combined with carboplatin and pirarubicin.
    Futani H; Fukunaga S; Tsukamoto Y; Terada N; Ono J; Okamoto N; Otsuka Y; Tanizawa T; Tomatsuri M; Yoshiya S
    Anticancer Res; 2012 Mar; 32(3):965-71. PubMed ID: 22399618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
    Cohen IJ
    Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Organ-preserving interventions in combined therapy of children and adolescents with osteosarcoma].
    Punanov IuA; Gafton GI; Gudz' IuV; Nabokov VV; Ivanova TV; Safonova SA; Levchenko EV; Kupatadze DD; Novik VI; Lazareva IuR; Krzhivitskiĭ PI; Petrov VG
    Vopr Onkol; 2012; 58(2):275-81. PubMed ID: 22774537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
    Meyers PA; Schwartz CL; Krailo M; Kleinerman ES; Betcher D; Bernstein ML; Conrad E; Ferguson W; Gebhardt M; Goorin AM; Harris MB; Healey J; Huvos A; Link M; Montebello J; Nadel H; Nieder M; Sato J; Siegal G; Weiner M; Wells R; Wold L; Womer R; Grier H
    J Clin Oncol; 2005 Mar; 23(9):2004-11. PubMed ID: 15774791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
    Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
    Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
    Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
    Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenic progenitor cell potency after high-dose chemotherapy (COSS-96).
    Jäger M; Schultheis A; Westhoff B; Krauspe R
    Anticancer Res; 2005; 25(2A):947-54. PubMed ID: 15868932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
    Zalupski MM; Rankin C; Ryan JR; Lucas DR; Muler J; Lanier KS; Budd GT; Biermann JS; Meyers FJ; Antman K
    Cancer; 2004 Feb; 100(4):818-25. PubMed ID: 14770440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
    Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma: the same old drugs or more?
    Bielack SS; Marina N; Ferrari S; Helman LJ; Smeland S; Whelan JS; Reaman GH
    J Clin Oncol; 2008 Jun; 26(18):3102-3; author reply 3104-5. PubMed ID: 18565904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.